CVS Health eases GLP-1 medication access via Eli Lilly partnership
CVS is collaborating with a pharmaceutical giant to provide a mobile app consumer touchpoint to purchase GLP-1 weight loss drugs.
The drugstore giant is collaborating with Eli Lilly to offer eligible Zepbound and Foundayo patients an additional access point at CVS Pharmacy through the CVS Health app. In addition, CVS has lowered the cost of MinuteClinic digital weight loss visits to $29, available 24/7.
Customers can use CVS scheduler technology to connect with licensed clinicians 24 hours a day through MinuteClinic, gain access to GLP-1 medications through CVS Pharmacy, receive personalized pharmacist support, and use digital tools to identify available savings options. No separate memberships or recurring monthly fees are required.
By early fourth quarter of 2026, CVS says eligible Zepbound and Foundayo patients will be able to view transparent pricing, including cash-pay options, in the CVS Health app for as early as same-day pickup at any store location nationwide.
CVS also offers a comprehensive approach to GLP-1 support at CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states. New offerings include expanded pharmacy support designed to help patients gain access to these treatments and stay on them, and a new $29 MinuteClinic online visit, with no membership or recurring monthly fee, that connects eligible patients with licensed clinicians who can evaluate and where clinically appropriate, prescribe GLP-1 therapy.
"Weight management is a deeply personal health journey, and too many people face barriers before they start treatment," said Sid Tenneti, CVS Health senior VP and interim president, pharmacy and consumer wellness. "CVS Health combines clinical care, pharmacy access, digital tools and trusted pharmacist support to make that journey simpler, more affordable, and more connected. Our collaboration with Lilly is one more way we're expanding direct to consumer access to help eligible patients find options that work best for them."
CVS’s collaboration with Eli Lilly follows a similar partnership the pharmaceutical company launched with Amazon that lets customers with a valid prescription order Foundayo through Amazon Pharmacy, see real-time medication availability and pricing, and receive same-day medication delivery directly to their door nationwide.
[READ MORE: Amazon expands same-day delivery range of Eli Lilly weight loss drugs]
CVS Pharmacy also participates in the Centers for Medicare & Medicaid Services Medicare GLP-1 Bridge program. Running through Dec. 31, 2027, the program offers eligible Medicare beneficiaries can access certain GLP-1 medications for $50 per month. The program is available nationally in accordance with state-level regulations and is designed for self-paying adults ages 18 to 64 who are overweight or living with obesity and intend to pay out of pocket for clinical weight loss services.
As of June 30, 2026, Woonsocket, R.I.-based CVS Health had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a pharmacy benefits manager with approximately 87 million plan members.
